Asklepios Kliniken Altona

Hamburg 22763

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Colorectal Cancer Metastatic, Metastatic Colorectal Cancer, Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• Sym004 Versus Futuximab or Modotuximab in Patients With mCRC — Stopped early
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed